Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology
Go back to Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology(AMEX: EHVVF) | Delayed: 0.00 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.00 | 52 Week High | $ | |||
Open | $0.00 | 52 Week Low | $ | |||
Day High | $0.00 | P/E | N/A | |||
Day Low | $0.00 | EPS | $ | |||
Volume | 131,080 |